2019 Q3 Form 10-Q Financial Statement
#000156459019042985 Filed on November 12, 2019
Income Statement
Concept | 2019 Q3 | 2018 Q3 | 2018 Q2 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $2.510M | $2.690M | $2.820M |
YoY Change | -6.69% | -15.41% | -23.16% |
% of Gross Profit | |||
Research & Development | $3.534M | $3.590M | $3.760M |
YoY Change | -1.56% | -46.89% | -23.89% |
% of Gross Profit | |||
Depreciation & Amortization | $10.00K | $10.00K | $0.00 |
YoY Change | 0.0% | 0.0% | |
% of Gross Profit | |||
Operating Expenses | $3.534M | $6.280M | $6.582M |
YoY Change | -43.73% | -36.82% | -23.57% |
Operating Profit | -$6.582M | ||
YoY Change | -23.57% | ||
Interest Expense | -$70.00K | -$290.0K | $287.0K |
YoY Change | -75.86% | 0.0% | -16.57% |
% of Operating Profit | |||
Other Income/Expense, Net | $170.0K | $60.00K | $29.00K |
YoY Change | 183.33% | -14.29% | -74.56% |
Pretax Income | -$5.940M | -$6.510M | -$6.840M |
YoY Change | -8.76% | -35.93% | -22.62% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$5.942M | -$6.510M | -$6.840M |
YoY Change | -8.73% | -35.93% | -22.64% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$1.980M | -$6.320M | -$6.980M |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q3 | 2018 Q3 | 2018 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $32.80M | $20.20M | $20.40M |
YoY Change | 62.38% | 61.6% | -10.13% |
Cash & Equivalents | $19.70M | $20.16M | $17.03M |
Short-Term Investments | $13.10M | $0.00 | $3.400M |
Other Short-Term Assets | $7.700M | $1.300M | $1.500M |
YoY Change | 492.31% | 0.0% | 87.5% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $40.50M | $21.50M | $21.90M |
YoY Change | 88.37% | 56.93% | -6.81% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.000M | $0.00 | $0.00 |
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $100.0K | $108.0K | $100.0K |
YoY Change | -7.41% | -91.69% | -92.86% |
Total Long-Term Assets | $1.100M | $86.00K | $100.0K |
YoY Change | 1179.07% | -93.86% | -92.86% |
TOTAL ASSETS | |||
Total Short-Term Assets | $40.50M | $21.50M | $21.90M |
Total Long-Term Assets | $1.100M | $86.00K | $100.0K |
Total Assets | $41.60M | $21.59M | $22.00M |
YoY Change | 92.72% | 42.95% | -11.65% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $800.0K | $1.277M | $1.600M |
YoY Change | -37.35% | -14.87% | -30.43% |
Accrued Expenses | $2.700M | $3.700M | $3.200M |
YoY Change | -27.03% | 8.82% | 6.67% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $5.500M | $7.300M | $7.300M |
YoY Change | -24.66% | 192.0% | 329.41% |
Total Short-Term Liabilities | $8.900M | $12.30M | $12.00M |
YoY Change | -27.64% | 66.22% | 71.43% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Other Long-Term Liabilities | $13.00K | $4.000K | $0.00 |
YoY Change | 225.0% | -96.0% | |
Total Long-Term Liabilities | $13.00K | $4.000K | $0.00 |
YoY Change | 225.0% | -99.92% | -100.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $8.900M | $12.30M | $12.00M |
Total Long-Term Liabilities | $13.00K | $4.000K | $0.00 |
Total Liabilities | $9.316M | $12.29M | $12.00M |
YoY Change | -24.2% | 0.74% | -3.23% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | |||
YoY Change | |||
Common Stock | $11.00K | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $32.29M | $9.296M | $9.975M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $41.60M | $21.60M | $22.00M |
YoY Change | 92.59% | 43.05% | -11.65% |
Cashflow Statement
Concept | 2019 Q3 | 2018 Q3 | 2018 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.942M | -$6.510M | -$6.840M |
YoY Change | -8.73% | -35.93% | -22.64% |
Depreciation, Depletion And Amortization | $10.00K | $10.00K | $0.00 |
YoY Change | 0.0% | 0.0% | |
Cash From Operating Activities | -$5.430M | -$5.450M | -$5.900M |
YoY Change | -0.37% | -47.19% | -45.42% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $0.00 | |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$10.69M | $3.400M | $640.0K |
YoY Change | -414.41% | -47.85% | -94.96% |
Cash From Investing Activities | -$10.69M | $3.400M | $640.0K |
YoY Change | -414.41% | -47.77% | -94.95% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 26.06M | 5.180M | 920.0K |
YoY Change | 403.09% | 5655.56% | -155.09% |
NET CHANGE | |||
Cash From Operating Activities | -5.430M | -5.450M | -5.900M |
Cash From Investing Activities | -10.69M | 3.400M | 640.0K |
Cash From Financing Activities | 26.06M | 5.180M | 920.0K |
Net Change In Cash | 9.940M | 3.130M | -4.340M |
YoY Change | 217.57% | -184.14% | -2270.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$5.430M | -$5.450M | -$5.900M |
Capital Expenditures | $0.00 | $0.00 | |
Free Cash Flow | -$5.450M | -$5.900M | |
YoY Change | -47.19% | -45.27% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
CY2019Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
5460000 | |
CY2019Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
545000 | |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11323000 | |
CY2019Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
13000 | |
CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
8000 | |
CY2019Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
409000 | |
CY2019Q3 | us-gaap |
Liabilities
Liabilities
|
9316000 | |
CY2019Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2019Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
11763000 | |
CY2019Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
11000 | |
CY2019Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
698032000 | |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-659469000 | |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3993000 | |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15324000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
237000 | ||
CY2018Q3 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
snss:LicenseAndOtherRevenueMember | |
snss |
Proceeds From Issuance Of Common Stock Through Equity Facilities Net
ProceedsFromIssuanceOfCommonStockThroughEquityFacilitiesNet
|
6040000 | ||
snss |
Proceeds From Exercise Of Stock Options And Stock Purchase Rights
ProceedsFromExerciseOfStockOptionsAndStockPurchaseRights
|
263000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
7000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-20611000 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.59 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-20618000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2185000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1154000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-420000 | ||
snss |
Increase Decrease In Accrued Clinical Expense
IncreaseDecreaseInAccruedClinicalExpense
|
-123000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-254000 | ||
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
28000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17898000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
6303000 | ||
snss |
Legal Expenses Accrued As Cost Of Equity Financing
LegalExpensesAccruedAsCostOfEquityFinancing
|
-33000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6815000 | ||
CY2018Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
20162000 | |
us-gaap |
Stock Issued1
StockIssued1
|
448000 | ||
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
21762000 | ||
snss |
Legal Expenses Accrued As Cost Of Equity Financing
LegalExpensesAccruedAsCostOfEquityFinancing
|
-125000 | ||
CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11739000 | |
CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9975000 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21544000 | |
CY2018Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9296000 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Significant Estimates and Judgments </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s condensed consolidated financial statements and accompanying notes thereto. Actual results could differ materially from these estimates. Estimates, assumptions and judgments made by management include those related to debt instruments, stock-based compensation, ROU assets, lease liabilities, and clinical trial accounting. </p> | ||
CY2019Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
100000 | |
CY2018Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
100000 | |
us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
400000 | ||
us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
400000 | ||
CY2019Q3 | snss |
Cash And Cash Equivalents Restricted Cash And Marketable Securities
CashAndCashEquivalentsRestrictedCashAndMarketableSecurities
|
38300000 | |
snss |
Number Of Product Candidates
NumberOfProductCandidates
|
2 | ||
CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
24934000 | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
24934000 | ||
CY2019Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
31526000 | |
CY2019Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
31526000 | |
CY2019Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
18446000 | |
CY2019Q3 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
18446000 | |
CY2019Q3 | snss |
Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
|
13080000 | |
CY2018Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
10845000 | |
CY2018Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
10845000 | |
CY2018Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
10845000 | |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
10845000 | |
us-gaap |
Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
|
0 | ||
CY2018 | us-gaap |
Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
|
0 | |
us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | ||
CY2019Q3 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | |
CY2018Q3 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | |
us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | ||
CY2019Q3 | us-gaap |
Notes Payable
NotesPayable
|
5500000 | |
CY2019Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
465000 | |
CY2018Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
637000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1276000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2185000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
400000 | ||
us-gaap |
Operating Lease Payments Use
OperatingLeasePaymentsUse
|
1400000 | ||
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
143000 | |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
579000 | |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
294000 | |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1016000 | |
CY2019Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
62000 | |
CY2019Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
954000 |